DENTSPLY SIRONA (NASDAQ:XRAY) Receives Hold Rating from Needham & Company LLC

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report)'s stock had its "hold" rating restated by investment analysts at Needham & Company LLC in a note issued to investors on Monday,Benzinga reports.

Several other equities analysts have also recently commented on the stock. UBS Group reduced their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Barrington Research boosted their price objective on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research note on Monday, May 12th. Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research note on Tuesday, April 15th. Piper Sandler reduced their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Finally, Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Sunday, July 13th. Ten analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA presently has an average rating of "Hold" and a consensus price target of $19.60.

DENTSPLY SIRONA Stock Performance

Shares of XRAY traded down $0.43 during trading hours on Monday, hitting $16.43. The company's stock had a trading volume of 1,165,053 shares, compared to its average volume of 2,833,983. The company has a market cap of $3.27 billion, a price-to-earnings ratio of -3.62, a PEG ratio of 1.17 and a beta of 0.94. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.10 and a quick ratio of 0.76. The business has a 50 day simple moving average of $16.05 and a two-hundred day simple moving average of $16.24. DENTSPLY SIRONA has a 52-week low of $12.16 and a 52-week high of $27.95.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.14. The firm had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The company's revenue was down 7.8% on a year-over-year basis. During the same quarter last year, the company earned $0.42 earnings per share. On average, equities analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently bought and sold shares of XRAY. Treasurer of the State of North Carolina boosted its stake in shares of DENTSPLY SIRONA by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after purchasing an additional 560 shares in the last quarter. Quarry LP boosted its stake in shares of DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after purchasing an additional 780 shares in the last quarter. Public Employees Retirement System of Ohio boosted its stake in shares of DENTSPLY SIRONA by 1.4% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier's stock valued at $983,000 after purchasing an additional 861 shares in the last quarter. Federated Hermes Inc. boosted its stake in shares of DENTSPLY SIRONA by 0.5% in the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock valued at $3,213,000 after purchasing an additional 915 shares in the last quarter. Finally, Gabelli Funds LLC boosted its stake in shares of DENTSPLY SIRONA by 1.0% in the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier's stock valued at $1,464,000 after purchasing an additional 1,000 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.